Insider buying and a recent FDA approval are catalysts that could send shares higher.
Category: Penny Stocks
Analysts Rate This $4 Stock a ‘Moderate Buy’ with 38% Upside Potential
by •
On analyzing the company’s stock charts, there seem to be multiple bullish indications…
Analysts Think This $1 Stock Has 58% Upside Potential
by •
On analyzing the company’s stock charts, there seem to be multiple bullish indications…
Trade This $4 Stock for a Potential Return of 32%-60%
by •
Insider buying and and expanded leadership are catalysts that could send shares higher.
Trade This $2 Stock for a 56%-100% Potential Return
by •
On analyzing the company’s stock charts, there seem to be multiple bullish indications…
Analysts Think This $2 Stock Has Nearly 80% Upside Potential
by •
On analyzing the company’s stock charts, there seem to be multiple bullish indications…
Analysts Think This $5 Stock Has 40% Upside Potential
by •
Insider buying and a business-to-business contract are catalysts that could send shares higher.
Trade This $2 Stock for a 42%-73% Potential Return
by •
On analyzing the company’s stock charts, there seem to be multiple bullish indications…
Analysts Think This $3 Stock Has 350%-Plus Upside Potential
by •
On analyzing the company’s stock charts, there seem to be multiple bullish indications.
Trade This $4 Stock for a 33%-67% Potential Upside
by •
A change in legislation and insider buying are catalysts that could send shares higher.